Compass Therapeutics, Inc. (CMPX) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts CMPX Hot Sheet
Join SI Premium – FREE
Compass Therapeutics, Inc. (NASDAQ: CMPX) reported Q3 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Compass Therapeutics, Inc. (CMPX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple suing OpenAI over alleged misappropriation of trade secrets
- HSBC Starts Parkway Life REIT (PREIT:SP) (PRKWF) at Buy
- Cognizant shareholder derivative settlement gets preliminary approval
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
